TY - JOUR
T1 - Celiac disease
T2 - Pathogenesis and serologic tests
AU - Murray, Joseph A.
PY - 1993
Y1 - 1993
N2 - The serological tests represent a significant advance in screening at-risk patients for celiac disease and probably should supplant other nonspecific methods for screening, such as 72-hr fecal fat, the d-xylose test, serum carotene, or small-bowel x-ray. The latter tests lack sensitivity, specificity, or simplicity. The published results suggest that the EMA IgA IFA is currently the screening tool of choice. The demonstration of the characteristic histological abnormalities of the intestinal abnormality and clinical improvement on a gluten-free diet is the gold standard for the diagnosis of celiac disease. Whether serological testing can substitute for intestinal biopsy in the diagnosis of celiac disease will depend on the experience obtained from more widespread application of these tests. The greater availability and more frequent use of these tests should increase the detection of a readily treatable condition, the diagnosis of which is often greatly delayed.
AB - The serological tests represent a significant advance in screening at-risk patients for celiac disease and probably should supplant other nonspecific methods for screening, such as 72-hr fecal fat, the d-xylose test, serum carotene, or small-bowel x-ray. The latter tests lack sensitivity, specificity, or simplicity. The published results suggest that the EMA IgA IFA is currently the screening tool of choice. The demonstration of the characteristic histological abnormalities of the intestinal abnormality and clinical improvement on a gluten-free diet is the gold standard for the diagnosis of celiac disease. Whether serological testing can substitute for intestinal biopsy in the diagnosis of celiac disease will depend on the experience obtained from more widespread application of these tests. The greater availability and more frequent use of these tests should increase the detection of a readily treatable condition, the diagnosis of which is often greatly delayed.
UR - http://www.scopus.com/inward/record.url?scp=43949165717&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=43949165717&partnerID=8YFLogxK
U2 - 10.1016/0197-1859(93)90025-F
DO - 10.1016/0197-1859(93)90025-F
M3 - Article
AN - SCOPUS:43949165717
SN - 0197-1859
VL - 13
SP - 105
EP - 112
JO - Clinical Immunology Newsletter
JF - Clinical Immunology Newsletter
IS - 9-10
ER -